Navigation Links
Amarin Provides 2010 Year-End Review to Shareholders
Date:1/31/2011

ary 16), CITI Healthcare Conference (New York City, March 2), RBC Capital Markets Healthcare Conference (New York City, March 2), ROTH Growth Conference (Laguna Niguel, March 14) and Needham & Company's Heathcare Conference (New York City, April 5).

I look forward to further accomplishments in the year ahead.

Sincerely,

Joseph S. Zakrzewski

Executive Chairman and CEO

About AMR101AMR101 is a semi-synthetic form of ethyl-EPA (ethyl icosapentate) that is being developed as a potentially best-in-class prescription medicine for treating patients with very high triglyceride levels (>500 mg/dL). AMR101 is also being evaluated as a potentially first-in-class therapy for patients with high triglyceride levels (≥200 and <500mg/dL) who are also on statin-therapy for elevated LDL-cholesterol levels. Significant scientific and clinical evidence supports the efficacy and safety of ethyl-EPA in reducing triglyceride levels.

About AmarinAmarin Corporation plc is a clinical-stage biopharmaceutical company with expertise in lipid science focused on the treatment of cardiovascular disease. The Company's lead product candidate is AMR101, the active ingredient in which is ethyl-EPA (ethyl icosapentate). On November 29, 2010, the Company reported positive top-line results from the MARINE trial, the first of its Phase 3 clinical trials of AMR101. In the MARINE trial, AMR101 was investigated as a treatment for very high triglycerides (>500 mg/dL). AMR101 is presently being investigated in a second Phase 3 clinical trial, the ANCHOR trial, for the treatment of patients with very high triglycerides (≥200 and <500mg/dL) who are also on statin therapy. The MARINE trial was, and the ANCHOR trial currently is, conducted under Special Protocol Assessment (SPA) agreements with the U.S. Food and Drug Administration (FDA). Amarin also has next-generation lipid candidates under evaluation for preclinical development.Investor
'/>"/>

SOURCE Amarin Corporation plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia
2. Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer
3. Amarin to Present at UBS Life Sciences Conference
4. Amarin Corporation to Host Investor Conference Call on Wednesday, November 10, 2010
5. Amarin to Present at Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference
6. Amarin Prices Public Offering of American Depositary Shares
7. Amarin Announces Underwriters Exercise of Over-Allotment Option
8. Amarin Announces Successful Completion of Offering of American Depositary Shares
9. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 6, 2015 /PRNewswire/--  Apexigen, Inc. , ... for the treatment of cancer and other life-threatening diseases, ... Partner to present at the Cavendish Global Health Impact ... 14 th in La Jolla, California ... help family offices and foundations develop and implement their ...
(Date:5/6/2015)... , May 6, 2015 Eli Lilly and ... establish a new drug delivery and device innovation center ... strategic location that will help attract top scientists and ... presence. The Lilly Cambridge Innovation Center, ... life science experts and organizations to explore how emerging ...
(Date:5/6/2015)... Neuralstem, Inc. (NYSE MKT: CUR), a biopharmaceutical ... molecule and cell therapy treatments for central nervous system ... to the position of Chief Financial Officer, effective ... Lloyd Jones brings to the position more than ...   Most recently, Mr. Lloyd Jones served as ...
Breaking Medicine Technology:Apexigen Selected to Present at Cavendish Global Health Impact Forum 2Apexigen Selected to Present at Cavendish Global Health Impact Forum 3Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 2Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 2Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 4
... 8 Globus Medical, Inc., the largest,privately held ... recognized,leader in motion preservation technology, today announced the ... IDE study. The,SECURE(R)-C device is designed to mimic ... alleviate pain and restore function as an alternative ...
... potential of asenapine in the treatment of ... schizophrenia and bipolar I disorder, ... announced that an overview of asenapine clinical trials,from the Olympia ... Psychiatric Association in Washington, D.C., May 3-8. Data from,the studies, ...
Cached Medicine Technology:Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7
(Date:5/6/2015)... 06, 2015 TMG Health, the leading ... Medicare Advantage, Medicare Part D and Managed Medicaid markets, ... Resilience Team category at the BCI North America Awards, ... recognize the outstanding contribution of business continuity professionals and ... Region, including the USA and Canada. The North America ...
(Date:5/6/2015)... Los Angeles (PRWEB) May 06, 2015 ... WaterAid, the #1 ranked international water, sanitation and hygiene ... work for communities across the world and it brings ... Lindsey Carnett, CEO of Marketing Maven. “The ongoing relationship ... the opportunities available for people to learn about and ...
(Date:5/6/2015)... May 06, 2015 Vancouver Chiropractic ... shared their new blog containing the Canadian Physical ... the Canadian Society for Exercise Physiology (CSEP). Since ... activity, health and fitness research and personal training ... exercise are highly beneficial and a rich resource ...
(Date:5/6/2015)... May 06, 2015 Healthcare jobs ... mark after launching in mid-February. The company connects hospitals, ... have previous experience in the industry. Likewise, job seekers ... According to Kyle Johnson, CTO, unique traffic to the ... first month: "Each new job posting brings targeted, interested ...
(Date:5/6/2015)... Chandler, AZ (PRWEB) May 06, 2015 ... now open for League Corporate Partner booth selection ... products and services to community college and university decision-makers ... take place November 1-4, 2015, at the Arizona Grand ... a private desert oasis on the doorstep of the ...
Breaking Medicine News(10 mins):Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3Health News:Vancouver Chiropractor Shares Canadian Physical Activity and Sedentary Behavior Guidelines by CSEP in New Blog 2Health News:Job Seekers Turn to JobMedic to Find Healthcare Positions - JobMedic.com Reaches 1,000 User Milestone 2Health News:STEMtech Conference Exhibitors Gain Access to Community College and University Representatives From Across the U.S. 2
... that has enhanced public understanding of biomedical researchWASHINGTON, ... (FBR) announced today it is accepting entries for ... The awards, named after FBR,s late chairman, ... reporting has enhanced public understanding of how the ...
... April 3 AstraZeneca (NYSE: AZN ) ... Drug Administration (FDA) posted to its web site -- ... 8, 2009 Psychopharmacologic Drugs Advisory Committee (PDAC) meeting. The ... efficacy data provided in supplemental new drug applications (sNDA) ...
... researchers say , , FRIDAY, April 3 (HealthDay News) -- ... insights into multiple sclerosis and other afflictions of the ... looking into why pregnant cats on a special diet ... including paralysis and vision, University of Wisconsin-Madison researchers found ...
... stock jeopardize shareholder interests?TEQUESTA, Fla., April 3 In ... and the Board of Directors of Energy Partners, LTD ... (CCC), personally holding a quarter million shares as well ... concern over a proposed bond buyout of the company,s ...
... Pass Bill to Protect Patient Access WASHINGTON, April 3 ... osteoporosis testing and reduce the physical and economic burden ... "Medicare Fracture Prevention and Osteoporosis Testing Act of 2009," ... and Olympia Snowe (R-ME) introduced the Senate version and ...
... 3 First Choice Professionals, LLC., today announced the ... Health Integration Solution ( THIS ). ... has joined forces with TIBCO Software Inc. (Nasdaq: ... brokering, SOA integration, and complex event processing. The partnership ...
Cached Medicine News:Health News:Foundation for Biomedical Research Announces Michael E. DeBakey Journalism Awards 2Health News:FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site 2Health News:FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site 3Health News:FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site 4Health News:FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site 5Health News:Cat Food-Linked Illness Yields Clues to MS 2Health News:Access to Osteoporosis Testing for Americans in Jeopardy 2Health News:Access to Osteoporosis Testing for Americans in Jeopardy 3Health News:Access to Osteoporosis Testing for Americans in Jeopardy 4Health News:Access to Osteoporosis Testing for Americans in Jeopardy 5Health News:FCP Announces Total Healthcare Integration Solution (THIS) Powered by TIBCO 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: